Subcutaneous tumorigenic data showed that FLCN‐SA inhibited tumor growth and tumor volume (Figure 6A,B), and the level of pT389‐S6K indicated that the inhibitory effect of FLCN‐SA on tumor growth was achieved mainly through inhibition of the mTORC1 pathway (Figure 6C). This evidence concerns the gene FLCN and neoplasm.